Purpose
to enhance clinical trial site capacity in preparation for conducting Phase 3 COVID-19 vaccine efficacy trials in low- and middle-income countries
Grantee
Division
Global Health
Date
JULY 2020
Region served
GLOBAL
Committed amount
$1,499,050
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology,
Vaccine Development
Duration (months)
11
Grantee location
Seoul, Korea, Republic of
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.